UPDATE 1-FDA rejects Adamis' emergency drug for severe allergic reaction

June 6 (Reuters) - Adamis Pharmaceuticals Corp said

on Monday the U.S. Food and Drug Administration rejected its

emergency treatment for acute anaphylaxis, a severe allergic

reaction, for the second...

Read more